1. Home
  2. PRTC vs ACCO Comparison

PRTC vs ACCO Comparison

Compare PRTC & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • ACCO
  • Stock Information
  • Founded
  • PRTC 2015
  • ACCO 1893
  • Country
  • PRTC United States
  • ACCO United States
  • Employees
  • PRTC N/A
  • ACCO N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • ACCO Publishing
  • Sector
  • PRTC Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • PRTC Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • PRTC 402.3M
  • ACCO 410.0M
  • IPO Year
  • PRTC N/A
  • ACCO N/A
  • Fundamental
  • Price
  • PRTC $16.74
  • ACCO $3.61
  • Analyst Decision
  • PRTC Buy
  • ACCO Buy
  • Analyst Count
  • PRTC 1
  • ACCO 1
  • Target Price
  • PRTC $45.00
  • ACCO $7.00
  • AVG Volume (30 Days)
  • PRTC 11.0K
  • ACCO 927.5K
  • Earning Date
  • PRTC 04-28-2025
  • ACCO 05-01-2025
  • Dividend Yield
  • PRTC N/A
  • ACCO 8.33%
  • EPS Growth
  • PRTC N/A
  • ACCO N/A
  • EPS
  • PRTC N/A
  • ACCO N/A
  • Revenue
  • PRTC $468,000.00
  • ACCO $1,666,200,000.00
  • Revenue This Year
  • PRTC N/A
  • ACCO N/A
  • Revenue Next Year
  • PRTC $160.00
  • ACCO $1.07
  • P/E Ratio
  • PRTC N/A
  • ACCO N/A
  • Revenue Growth
  • PRTC N/A
  • ACCO N/A
  • 52 Week Low
  • PRTC $13.30
  • ACCO $3.47
  • 52 Week High
  • PRTC $32.98
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 47.62
  • ACCO 34.29
  • Support Level
  • PRTC $13.30
  • ACCO $3.55
  • Resistance Level
  • PRTC $16.75
  • ACCO $3.79
  • Average True Range (ATR)
  • PRTC 0.98
  • ACCO 0.22
  • MACD
  • PRTC -0.03
  • ACCO -0.02
  • Stochastic Oscillator
  • PRTC 51.39
  • ACCO 14.74

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

Share on Social Networks: